Polymorphisms in XPC Gene and Risk of Uterine Leiomyoma in Reproductive Women

[1]  Koichiro Watanabe,et al.  Age-related dysfunction of the DNA damage response in intestinal stem cells , 2019, Inflammation and regeneration.

[2]  M. Stampfer,et al.  Delayed γH2AX foci disappearance in mammary epithelial cells from aged women reveals an age-associated DNA repair defect , 2019, Aging.

[3]  W. Han,et al.  Prognostic effects of abnormal DNA damage response protein expression in breast cancer , 2019, Breast Cancer Research and Treatment.

[4]  T. Edwards,et al.  Evaluating risk factors for differences in fibroid size and number using a large electronic health record population. , 2018, Maturitas.

[5]  Qiong Zhang,et al.  The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility , 2018, Bioscience reports.

[6]  I. Ellis,et al.  Checkpoint Kinase 1 Expression Predicts Poor Prognosis in Nigerian Breast Cancer Patients , 2017, Molecular Diagnosis & Therapy.

[7]  Wei Zhang,et al.  The association of genetic variations in DNA repair pathways with severe toxicities in NSCLC patients undergoing platinum‐based chemotherapy , 2017, International journal of cancer.

[8]  Kyungeun Kim,et al.  High excision repair cross-complementation group 1 expression is associated with favorable prognostic factors in breast cancer. , 2017, Oncology letters.

[9]  Wen-Shin Chang,et al.  Contribution of Double-strand Break Repair Gene Nijmegen Breakage Syndrome 1 Genotypes, Gender Difference and Smoking Status to Taiwanese Lung Cancer. , 2017, Anticancer research.

[10]  Amanda B. Parris,et al.  p53 pathway determines the cellular response to alcohol-induced DNA damage in MCF-7 breast cancer cells , 2017, PloS one.

[11]  Jingsheng Hua,et al.  Dysfunction of microRNA-32 regulates ubiquitin ligase FBXW7 in multiple myeloma disease , 2016, OncoTargets and therapy.

[12]  Yu-qin Pan,et al.  Nucleotide excision repair pathway gene polymorphisms are linked to breast cancer risk in a Chinese population , 2016, Oncotarget.

[13]  W. Xue,et al.  Association of XPC Gene Polymorphisms with Colorectal Cancer Risk in a Southern Chinese Population: A Case-Control Study and Meta-Analysis , 2016, Genes.

[14]  W. Xue,et al.  Polymorphisms in the XPC gene and gastric cancer susceptibility in a Southern Chinese population , 2016, OncoTargets and therapy.

[15]  J. Donnez,et al.  Uterine fibroid management: from the present to the future , 2016, Human reproduction update.

[16]  B. Tarlatzis,et al.  Infertility and uterine fibroids. , 2016, Best practice & research. Clinical obstetrics & gynaecology.

[17]  H. Xia,et al.  Association of potentially functional variants in the XPG gene with neuroblastoma risk in a Chinese population , 2016, Journal of cellular and molecular medicine.

[18]  Wen-Shin Chang,et al.  Contribution of X-Ray Repair Complementing Defective Repair in Chinese Hamster Cells 3 (XRCC3) Genotype to Leiomyoma Risk. , 2015, Anticancer research.

[19]  J. Kładny,et al.  Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population , 2014, Molecular Biology Reports.

[20]  Guan Zhang,et al.  Association between CCND1 and XPC polymorphisms and bladder cancer risk: a meta-analysis based on 15 case–control studies , 2014, Tumor Biology.

[21]  Jing He,et al.  Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: A meta‐analysis , 2013, International journal of cancer.

[22]  R. Scott,et al.  Xeroderma pigmentosum genes and melanoma risk , 2013, International journal of cancer.

[23]  Hongbing Shen,et al.  Potentially functional polymorphisms in DNA repair genes and non‐small‐cell lung cancer survival: A pathway‐based analysis , 2012, Molecular carcinogenesis.

[24]  J. Neal,et al.  Etiology, diagnosis, and management of uterine leiomyomas. , 2012, Journal of midwifery & women's health.

[25]  Menghong Sun,et al.  Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations , 2012, Human Genetics.

[26]  A. Engin,et al.  DNA repair enzyme polymorphisms and oxidative stress in a Turkish population with gastric carcinoma , 2011, Molecular Biology Reports.

[27]  Xi-Dai Long,et al.  Genetic polymorphisms in DNA repair genes XPC, XPD, and XRCC4, and susceptibility to Helicobacter pylori infection‐related gastric antrum adenocarcinoma in Guangxi population, China , 2010, Molecular carcinogenesis.

[28]  D. Baird,et al.  Growth of uterine leiomyomata among premenopausal black and white women , 2008, Proceedings of the National Academy of Sciences.

[29]  F. Tsai,et al.  X-ray repair cross-complementing group 4 (XRCC4) promoter -1394( *)T-related genotype, but not XRCC4 codon 247/intron 3 or xeroderma pigmentosum group D codon 312, 751/promoter -114, polymorphisms are correlated with higher susceptibility to myoma. , 2008, Fertility and sterility.

[30]  I. Manyonda,et al.  Clinical presentation of fibroids. , 2008, Best practice & research. Clinical obstetrics & gynaecology.

[31]  Paul I Lee,et al.  Predictors of leiomyoma recurrence after laparoscopic myomectomy. , 2007, Journal of minimally invasive gynecology.

[32]  E. Parlanti,et al.  New functions of XPC in the protection of human skin cells from oxidative damage , 2006, The EMBO journal.

[33]  N. Park,et al.  DNA repair gene XRCC1 Arg399Gln polymorphism is associated with increased risk of uterine leiomyoma. , 2005, Human reproduction.

[34]  Richard D. Wood,et al.  Human DNA Repair Genes , 2001, Science.

[35]  M. Rein,et al.  Advances in uterine leiomyoma research: the progesterone hypothesis. , 2000, Environmental health perspectives.

[36]  P. J. van der Spek,et al.  Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. , 1998, Molecular cell.

[37]  W. Catherino,et al.  Uterine fibroids , 2016, Nature Reviews Disease Primers.

[38]  Shujuan Yang,et al.  Genetic variability of ERCC1 genes in NER pathway influences the treatment outcome of gastric cancer. , 2015, International journal of clinical and experimental pathology.